Health News Archive - May 07, 2009
AMSTERDAM, May 7 /PRNewswire-FirstCall/ -- Amsterdam Molecular Therapeutics (Euronext: AMT), a leader in the field of human gene therapy, announced today the treatment of the first patient in a preregistration clinical trial with Glybera(TM).
U.S. researchers failed to find most genetic markers of influenza infection severity identified from past outbreaks in the current H1N1 flu.
Pixantrone Named-Patient Program Initiated in Europe SEATTLE, May 7 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. (CTI) (Nasdaq and MTA: CTIC) reported recent accomplishments and financial results for the quarter ended March 31, 2009.
People with relatives who have had rotator cuff tears are at greater risk for similar injuries, U.S. researchers say.
LONDON, May 7 /PRNewswire/ -- The Frost & Sullivan "2009 European Molecular Diagnostics for Infectious Diseases Product Line Strategy of the Year Award", is presented to SIRS-Lab GmbH.
MACCLESFIELD, England, May 7 /PRNewswire-FirstCall/ -- Cyprotex today (7th May 2009) launches Cloe(R) Gateway, a new secure web portal for access to drug discovery services.
SANTA MONICA, Calif., May 7 /PRNewswire-FirstCall/ -- Cord Blood America, Inc.
Even Greater Savings Would Result from Increasing Funding for FDA, Creating a Workable Pathway for Biogenerics, Expanding Utilization of Generics ARLINGTON, Va., May 7 /PRNewswire/ -- The Generic Pharmaceutical Association (GPhA) today released the results of an independent analysis commissioned from IMS Health, the leading healthcare market intelligence company, revealing that using generic pharmaceuticals saved the American health care system more than $734 billion in the last decade (1999-2008), with approximately $121 billion in savings in 2008 alone.
ARLINGTON, Va., May 7 /PRNewswire/ -- The Generic Pharmaceutical Association (GPhA) will discuss the results of an independent analysis commissioned from IMS Health, the leading healthcare market intelligence company, revealing that generic pharmaceutical utilization has contributed $734 billion in savings to the American health care system in the last decade. What: New Economic Analysis Reveals Extraordinary Savings of $734 Billion Produced by Using Generic Medicines (1999-2008) When: Thursday, May 7, 2009 at 10 am EDT Where: http://www.videonewswire.com/event.asp?id=58424 How: Live over the Internet -- Simply log on to the web at the address above. Call In for Q&A: 1-800-860-2442 Passcode: GPHA Call GPhA represents the manufacturers and distributors of finished generic pharmaceuticals, manufacturers and distributors of bulk pharmaceutical chemicals, and suppliers of other goods and services to the generic
Total Revenue $11.1 Million, 58% Increase From Prior Year Recurring Revenue Climbs to All Time High of $4.3 Million Record Gross Margin of 69% Operating Expenses Decrease 17% from Prior Year, Resulting in a 46% Reduction in Operating Loss ST.